Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
'It's a long way to Tipperary..."
MA (200) 0.0294... Will it get back there?
It was about ARYC... The same kind of comments...
ABOUT AXIS
Rakeman Thursday, 07/23/15 02:56:10 PM
Re: joever post# 14946
Post # of 14960
This DILUTION scam heading to 0.0017
Note holders dumping again
enjoy
You should change your name to Chameleon...
To get people to sell, so that he could buy cheap?
The "positive efficacy" news came, but the price has not gone much higher... Give us more details about the situation!
Celgene pays $1B in landmark deal to buy into Juno's pipeline of CAR-T drugs
June 29, 2015 | By John Carroll
Celgene ($CELG) is paying about $1 billion to move to the front of the hectic race to build new CAR-T cancer therapies. The Big Biotech is shelling out $150 million upfront and paying $93 a share--a huge premium--to snap up 9.1 million shares of Juno Therapeutics ($JUNO), inking a global collaboration to develop and commercialize new immuno-oncology therapies.
The deal--which also covers Juno's work on TCRs--gives Celgene 10% of Juno's stock and an option on co-commercializing the biotech's oncology and cell therapy autoimmune product candidates, including Juno's lead CD19 and CD22 directed CAR-T product candidates. B-cell maturation antigen, or BCMA, is excluded as a target in this collaboration. And the aggressive, hematology-focused execs at Celgene also gained the right to boost their ownership of Juno to a hefty 30% of all outstanding shares over the 10-year term of the deal while appointing R&D director Tom Daniel as a director on Juno's board.
The deal puts a bright spotlight on the hot R&D race to develop new drugs that re-engineer T cells, arming them with chimeric antigen receptors so that they target cancer cells. Juno and Novartis ($NVS) are widely viewed as the leaders in the field, with Juno vaulting from a startup to a major new force in the biotech world in less than two years--an unprecedented achievement in the industry.
This is getting too low! Is is going to close at the lowest?
And what did he say today?
Last? What comes next?
More news on Monday?
"The Company is presently conducting several animal studies for PRP and is expecting initial results mid-June, followed by additional data late July." Any "initial results?"
What does Parker say? Why did they not present more specific data?
Lots of abrupt dips today...
$0.1161 on 6/16... 1 and 6 in a magical combination...
30 millions...
VNDM and NITE are the main blockers...
As soon as VNDM will go up, the price can go up...
VNDM needs shares...
Follow VNDM!
VNDM moved a bit up...
VNDM RAISE THE ASK!
Very detailed... When do you expect the good news? What about the email you received almost a week ago?
Do you expect any pump for this stock soon?
Huge bids and asks...
So are you ready to rake the cheap shares?
The Marcum MicroCap Conference is dedicated to providing a forum where publicly traded companies under $500 million in market capitalization can network with the investment community. The conference features presentations by CEOs and CFOs from six principal industry sectors, expert panels moderated by industry leaders, and the opportunity to meet with management of these companies on a One-on-One basis.
Marcum is again proud to partner with KCSA Strategic Communications and Launchpad Investor Relations to present our annual MicroCap Conference.
This year, in order to accommodate investor interest and provide a showcase for early stage growth companies, the conference is being expanded to include an additional half-day dedicated exclusively to nanocap and pre-IPO enterprises. Presentations from these companies will take place on Day One, followed by presentations from more mature publicly traded microcap companies on Day Two.
The conference will feature the following presentation tracks:
Technology, Media & Internet
Software & Business Services
Life Science & Healthcare
Retail & Consumer Products
Energy & Natural Resources
Industrials
Other
In addition, the conference will also include a full agenda of expert panel discussions on issues of strategic importance to small cap issuers and investors.
This event attracts fund managers and high net worth investors who focus on small cap equities. Over 2,000 participants from all segments of the microcap market are expected to participate. Attendees will include senior management, finance and legal executives, venture and lower middle-market private equity investors, institutional investors, directors, investment bankers, buy- and sell-side analysts, and service providers to the microcap marketplace.
Marcum MicroCap Conference - May 27 & 28, 2015
March 4, 2015
Momentum Building for 2015 Marcum MicroCap Conference
New York City, NY - Momentum for the 2015 Marcum MicroCap Conference is building at a pace that already supersedes last year’s record level, with all available sponsorships sold out nearly three months in advance. The annual investor event will take place May 27-28 at the Grand Hyatt Hotel in New York City. It is presented by the SEC Services Practice of Marcum LLP, a top national accounting and advisory services firm.
In addition, presenting company slots are rapidly filling up and Marcum anticipates a full slate, with demand exceeding availability, as in past years. Attendee registration is also outpacing the record level at this time last year. In 2014, over 125 companies presented and more than 2000 participants from all segments of the microcap market attended.
"The early commitments of so many sponsors, presenting companies and attendees is a testament to the stature that the Marcum MicroCap Conference has gained in the emerging growth market in just four short years," said David C. Bukzin, Partner-in-Charge of Marcum's SEC Practice Group and producer of the event. "With two-thirds of our 2015 sponsors returning from previous years, we take it as confirmation of the value the conference creates for both investors and presenting companies. We expect that this year’s conference will be the best yet."
Top sponsors this year include H. C. Wainwright & Co., LLC; Maxim Group LLC, National Securities Corporation, and ROTH Capital Partners, LLC, in the Platinum category. Complete conference details, including the full list of sponsors, are available at www.marcumllp.com/microcap.
About the Marcum MicroCap Conference
The annual Marcum MicroCap Conference introduces investors to superior, undiscovered companies with under $500 million in market capitalization. Since its inception, it has become a cornerstone event for the microcap market, featuring presentations by CEOs and CFOs from breakthrough high-growth companies, top picks by leading small cap analysts, and insightful commentary on successful investment strategies and sectors. Featured companies represent six industry sectors, including Technology, Media & Internet; Software & Business Services; Life Science & Healthcare; Retail & Consumer Products; Energy & Natural Resources; and Industrials. The conference additionally includes a full agenda of panel discussions on issues of strategic importance to small cap issuers and investors.
The event attracts top fund managers and qualified high net worth investors focusing on small cap equities. Over 2,000 participants from all segments of the microcap market attend each year, including senior management, finance and legal executives, venture and lower middle-market private equity investors, institutional investors, directors, investment bankers, buy- and sell-side analysts, and service providers to the microcap marketplace.
For complete information about the 2015 Marcum MicroCap Conference, including presenting companies and sponsorship details, visit www.marcumllp.com/microcap.
Marcum is a registered Public Company Accounting Oversight Board (PCAOB) firm. Marcum's Assurance Division provides the most up-to-date service and guidance on SEC accounting and reporting issues. Services include Financial Statement Audits in accordance with PCAOB standards; Tax Compliance and Advisory Services; Due Diligence; Agreed-Upon Procedures and Other Attest Work; Internal Audit Services; Sarbanes-Oxley Section 404 Compliance Services and Software; Technical Accounting Assistance; and IPO Assistance. Marcum’s SEC Practice led the audit industry in most net new public company clients in the fourth quarter of 2013.
About Marcum LLP
Marcum LLP is one of the largest independent public accounting and advisory services firms in the United States. Ranked #15 nationally, Marcum LLP offers the resources of 1,300 professionals, including over 160 partners, in 23 offices throughout the U.S., Grand Cayman and China. Headquartered in New York City, the Firm's presence runs deep, with full-service offices strategically located in major business markets. Marcum is a member of the Marcum Group, an organization providing a comprehensive range of professional services spanning accounting and advisory, technology solutions, wealth management, and executive and professional recruiting. The Marcum Group companies include Marcum LLP; Marcum Technology LLC; Marcum Search LLC; Marcum Financial Services LLC; Marcum Bernstein & Pinchuk LLP; and MarcumBuchanan Associates LLC.
February 10, 2015
Marcum Announces Platinum Sponsors for the 2015 Marcum MicroCap Conference
New York City, NY - Four investment banks have signed on as Platinum Sponsors for this year's annual Marcum MicroCap Conference, taking place May 27-28 at the Grand Hyatt Hotel in New York City. The conference is presented by Marcum LLP, a top national accounting and advisory services firm.
The 2015 Platinum Sponsors include:
H. C. Wainwright & Co., LLC, an investment bank dedicated to providing corporate finance, strategic advisory and related services to public and private growth companies across multiple sectors and regions.
Maxim Group LLC, a leading boutique investment banking, securities, and investment management firm providing world-class investment banking, asset management, research and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
National Securities Corporation, one of the country's largest independent broker-dealers, with registered representatives located throughout the United States.
ROTH Capital Partners, LLC, a relationship-driven investment bank focused on serving emerging growth companies and their investors.
H.C. Wainwright & Co., Maxim Group and National Securities Corporation are all returning Platinum Sponsors, having been top corporate supporters of the conference in 2014. ROTH Capital Partners was a Silver Sponsor last year.
"We place a very high premium on the support of these four outstanding companies for the Marcum MicroCap Conference," said David C. Bukzin, Partner-in-Charge of Marcum's SEC Practice Group and producer of the event. "We are especially gratified that all four companies are returning after having been sponsors last year, which is an independent confirmation of the value the conference provides for both sponsors and presenting companies."
The annual Marcum MicroCap Conference introduces investors to superior, undiscovered companies with under $500 million in market capitalization. Since its inception, it has become a cornerstone event for the microcap market, featuring presentations by CEOs and CFOs from breakthrough high-growth companies, top picks by leading small cap analysts, and insightful commentary on successful investment strategies and sectors. Featured companies represent six industry sectors, including Technology, Media & Internet; Software & Business Services; Life Science & Healthcare; Retail & Consumer Products; Energy & Natural Resources; and Industrials. The conference additionally includes a full agenda of panel discussions on issues of strategic importance to small cap issuers and investors.
The event attracts top fund managers and qualified high net worth investors focusing on small cap equities. Over 2,000 participants from all segments of the microcap market attend each year, including senior management, finance and legal executives, venture and lower middle-market private equity investors, institutional investors, directors, investment bankers, buy- and sell-side analysts, and service providers to the microcap marketplace.
For complete information about the 2015 Marcum MicroCap Conference, including presenting companies and sponsorship details, visit www.marcumllp.com/microcap.
Marcum is a registered Public Company Accounting Oversight Board (PCAOB) firm. Marcum's Assurance Division provides the most up-to-date service and guidance on SEC accounting and reporting issues. Services include Financial Statement Audits in accordance with PCAOB standards; Tax Compliance and Advisory Services; Due Diligence; Agreed-Upon Procedures and Other Attest Work; Internal Audit Services; Sarbanes-Oxley Section 404 Compliance Services and Software; Technical Accounting Assistance; and IPO Assistance. Marcum’s SEC Practice led the audit industry in most net new public company clients in the fourth quarter of 2013.
Rakeman Thursday, 05/14/15 10:18:58 AM
Re: None
Post # of 15452
The BREAKOUT triangle is looking even BETTER now, we are near the APEX !, we now have 3 waves.typical breakout happens on 3rd
Take a look, this small down wave on this volume made it even look picture perfect for powerful BREAKOUT!. The traingle is now almost complete.
Few stock breakout on 2nd, which we had yesterday, 90% breakout on 3rd wave where the final APEX is created,
http://stockcharts.com/h-sc/ui?s=ppch
05/15/15 Special day! Once in 100 years!
Is the 10Q coming tomorrow?
Yes, better news are expected!
Nothing came out the Golden Cross... Yet...
All these $10.000 on Level 2 are so deceiving...
I would buy 1 million at 0.035... It is highly risky...
The NY Times presentation was fluff...
We need some news, not just technicalities...